These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 947510

  • 1. Combination chemotherapy and adriamycin in patients with advanced breast cancer. A Southwest Oncology Group study.
    Hoogstraten B, George SL, Samal B, Rivkin SE, Costanzi JJ, Bonnet JD, Thigpen T, Braine H.
    Cancer; 1976 Jul; 38(1):13-20. PubMed ID: 947510
    [Abstract] [Full Text] [Related]

  • 2. A comparison of cyclophosphamide, adriamycin, 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, prednisone (CMFVP) in patients with metastatic breast cancer: a Southeastern Cancer Study Group project.
    Smalley RV, Carpenter J, Bartolucci A, Vogel C, Krauss S.
    Cancer; 1977 Aug; 40(2):625-32. PubMed ID: 329975
    [Abstract] [Full Text] [Related]

  • 3. Adriamycin in combination for the treatment of breast cancer: a Southwest Oncology Group study.
    Tranum B, Hoogstraten B, Kennedy A, Vaughn CB, Samal B, Thigpen T, Rivkin S, Smith F, Palmer RL, Costanzi J, Tucker WG, Wilson H, Maloney TR.
    Cancer; 1978 Jun; 41(6):2078-83. PubMed ID: 657081
    [Abstract] [Full Text] [Related]

  • 4. Mitoxantrone combined to vincristine, cyclophosphamide and fluorouracil in advanced breast cancer.
    Metz R, Delgado M, Keiling R, Cappelaere P, Armand JP, Prevot G, Misset JL, Grimbert J, Mathe G.
    Invest New Drugs; 1985 Jun; 3(2):163-6. PubMed ID: 4019119
    [Abstract] [Full Text] [Related]

  • 5. Adriamycin plus vincristine compared to and combined with cyclophosphamide, methotrexate, and 5-fluorouracil for advanced breast cancer.
    De Lena M, Brambilla C, Morabito A, Bonadonna G.
    Cancer; 1975 Apr; 35(4):1108-15. PubMed ID: 1116104
    [Abstract] [Full Text] [Related]

  • 6. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
    Rivkin SE, Green SJ, Lew D, Costanzi JJ, Athens JW, Osborne CK, Vaughn CB, Martino S.
    Cancer; 2003 Jan 01; 97(1):21-9. PubMed ID: 12491501
    [Abstract] [Full Text] [Related]

  • 7. Vincristine, doxorubicin, and cyclophosphamide versus low-dose intravenous cyclophosphamide, methotrexate, and 5-fluorouracil in advanced breast cancer: a randomized trial of the Piedmont Oncology Association.
    Muss HB, Richards F, Jackson DV, Cooper MR, White DR, Stuart JJ, Ramseur W, Christian RM, Wells HB, Pope E, Spurr CL.
    Cancer; 1982 Dec 01; 50(11):2269-74. PubMed ID: 6754062
    [Abstract] [Full Text] [Related]

  • 8. [Chemotherapy of metastasizing breast cancer. Adriamycin mono and combination therapy after LMFP pretreatment].
    Waibel PJ, Jungi WF, Senn HJ.
    Dtsch Med Wochenschr; 1983 Dec 02; 108(48):1827-32. PubMed ID: 6641535
    [Abstract] [Full Text] [Related]

  • 9. Adriamycin, dibromodulcitol, and mitomycin combination chemotherapy for patients with metastatic breast carcinoma previously treated with cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisone.
    Pinnamaneni K, Yap HY, Buzdar AU, Distefano A, Blumenschein GR.
    Cancer; 1984 May 01; 53(9):1841-4. PubMed ID: 6546706
    [Abstract] [Full Text] [Related]

  • 10. Combination chemotherapy of advanced breast cancer. Comparison of dibromodulcitol, doxorubicin, vincristine, and fluoxymesterone to thiotepa, doxorubicin, vinblastine, and fluoxymesterone: an Eastern Cooperative Oncology Group Study.
    Skeel RT, Andersen JW, Tormey DC, Benson AB, Asbury RF, Falkson G.
    Cancer; 1989 Oct 01; 64(7):1393-9. PubMed ID: 2505919
    [Abstract] [Full Text] [Related]

  • 11. Combination chemotherapy for advanced breast cancer: two regimens containing adriamycin.
    Kennealey GT, Boston B, Mitchell MS, Knobf MK, Bobrow SN, Pezzimenti JF, Lawrence R, Bertino JR.
    Cancer; 1978 Jul 01; 42(1):27-33. PubMed ID: 667798
    [Abstract] [Full Text] [Related]

  • 12. VP-16 and adriamycin in patients with advanced breast cancer.
    Vaughn CB, Maniscalco-Greb E, Lockhard C, Groshko G, Enochs K, Duffin H, Demitrish M.
    Am J Clin Oncol; 1982 Oct 01; 5(5):505-9. PubMed ID: 6897491
    [Abstract] [Full Text] [Related]

  • 13. Activity of adriamycin in metastatic breast cancer resistant to a combination regimen with cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prdnisone.
    Frederiksen PL, Joergensen ST, Roesdahl K, Thomsen J, Mouridsen HT.
    Cancer Treat Rep; 1978 Mar 01; 62(3):449-50. PubMed ID: 348314
    [No Abstract] [Full Text] [Related]

  • 14. Adriamycin versus methotrexate in five-drug combination chemotherapy for advanced breast cancer: a randomized trial.
    Muss HB, White DR, Richards F, Cooper MR, Stuart JJ, Jackson DV, Rhyne L, Spurr CL.
    Cancer; 1978 Nov 01; 42(5):2141-8. PubMed ID: 363253
    [Abstract] [Full Text] [Related]

  • 15. Prolonged remissions of metastatic breast cancer achieved with a six-drug regimen of relatively low toxicity.
    Hirshaut Y, Kesselheim H.
    Cancer; 1983 Jun 01; 51(11):1998-2004. PubMed ID: 6687698
    [Abstract] [Full Text] [Related]

  • 16. Combination chemotherapy in disseminated carcinoma of the breast.
    Stutz FH, Blom J, Tormey DC.
    Oncology; 1974 Jun 01; 29(2):139-46. PubMed ID: 4525917
    [No Abstract] [Full Text] [Related]

  • 17. A preliminary analysis of combination therapy with vincristine, adriamycin, and prednimustine (VAP) in advanced breast cancer: a phase II study.
    Lehnert M, Biffl G, Wascher H, Jordis-Lohausen K, Wählby S.
    Semin Oncol; 1986 Mar 01; 13(1 Suppl 1):32-4. PubMed ID: 3754064
    [Abstract] [Full Text] [Related]

  • 18. Chemotherapy for breast cancer.
    Allegra JC, Lippman ME.
    Compr Ther; 1979 Feb 01; 5(2):13-7. PubMed ID: 428200
    [Abstract] [Full Text] [Related]

  • 19. Chemotherapy of advanced breast cancer. A general survey.
    Lyss AP, Loeb V.
    Cancer; 1984 Feb 01; 53(3 Suppl):778-82. PubMed ID: 6546358
    [Abstract] [Full Text] [Related]

  • 20. A randomized multicenter trial of cyclophosphamide, Novantrone and 5-fluorouracil (CNF) versus cyclophosphamide, Adriamycin and 5-fluorouracil (CAF) in patients with metastatic breast cancer.
    Bennett JM, Byrne P, Desai A, White C, DeConti R, Vogel C, Krementz E, Muggia F, Doroshow J, Plotkin D.
    Invest New Drugs; 1985 Feb 01; 3(2):179-85. PubMed ID: 3894279
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.